Treatment of Bacterial Meningitis in Infants Aged 1 to 23 Months

Bacterial meningitis in the first two years of life requires prompt recognition and an age-specific treatment strategy. The approach for infants aged 1 to 23 months is shaped by the pathogens most likely at this stage of development and by the narrow therapeutic window in which corticosteroid adjuncts must be timed relative to antibiotic initiation.

Clinical Scenario

This protocol applies to children aged 1 to 23 months presenting with suspected or confirmed bacterial meningitis. Because the causative organism is typically unknown at the time of initial presentation, empiric therapy must cover the pathogens most prevalent in this age group while awaiting culture and sensitivity results.

Clinical Goal

The primary treatment goal is clinical improvement within 48 hours of initiating appropriate therapy. Absence of improvement at that mark prompts reassessment, including consideration of cerebrospinal fluid re-evaluation.

Treatment Approach — Partial Overview

Management centres on an intravenous antibiotic combination, with a corticosteroid added — in eligible patients — immediately before or alongside the first antibiotic dose. An alternative antibiotic combination exists for specific clinical circumstances.

Full regimen details, antibiotic selection criteria, corticosteroid eligibility, and de-escalation guidance are available in the complete structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

Children 1 to 23 months of age
Vancomycin plus ceftriaxone
Alternative: meropenem (Merrem IV) plus vancomycin
Because the etiology is not known at presentation, dexamethasone should be given before or at the time of initial antibiotics while awaiting the final culture results in all patients older than six weeks with suspected bacterial meningitis.
Dexamethasone can be discontinued after four days or earlier if the pathogen is not H. influenzae or S. pneumoniae, or if CSF findings are more consistent with aseptic meningitis.
The best evidence supports the use of dexamethasone 10 to 20 minutes before or concomitantly with antibiotic administration in the following groups: infants and children with H. influenzae type B, adults with S. pneumoniae, or patients with Mycobacterium tuberculosis without concomitant human immunodeficiency virus infection.
Repeat LP is generally not needed but should be considered to evaluate CSF parameters in persons who are not clinically improving after 48 hours of appropriate treatment.

View source ↗